Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT07320911
Active, not recruiting Not applicable

Patient-Specific Guides for Gap Pediatric Arthroplasty

NCT07320911 · tracked via the Priya Life Science Egypt tracker
Sponsor
Alexandria University
Phase
Not applicable
Started
2025-01-01
Last updated
2026-01-06

Condition(s) studied

Temporomandibular Joint Ankylosis

Investigational drug(s) / intervention(s)

Patient-Specific Narrow-Slit Osteotomy Guides

Patient-Specific Narrow-Slit Osteotomy Guides: Patient-Specific Narrow-Slit Osteotomy Guides for gap arthroplasty

Study summary

To date, few reports have combined patient-specific guides with piezoelectric devices for gap arthroplasty in children. This study evaluates the feasibility, accuracy, and early outcomes of this approach, hypothesizing that the combination of narrow-slit surgical guides and piezoelectric osteotomy provides safe and reproducible results in pediatric TMJ ankylosis.

Eligibility

Sex
ALL
Min age
—
Max age
15 Years
Healthy volunteers
No
Inclusion Criteria: 1. patient with TMJ ankylosis. 2. less than 15 years old at the time of surgery Exclusion Criteria: 1. Fibrous ankylosis without bony involvement 2. Associated craniofacial syndromes 3. Patients with systemic conditions contraindicating surgery

Primary outcome measure(s)

  • accuracy of the guide — 1 week
    Follow-up imaging was performed 1 week postoperatively using computed tomography (CT). Digital superimposition of the preoperative virtual plan and postoperative CT scans was carried out to assess the accuracy of osteotomy execution.

Trial sites (1)

FacilityCityRegionStatus
Faculty of Dentistry, Alexandria University Alexandria Alexandria Governorate

More Alexandria University trials in Egypt

VEXUS and Assessment of Dry Weight of Patients on Hemodialysis Recruiting
Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal Defect Recruiting
Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children Recruiting
Intravenous Lidocaine Infusion Versus Intravenous Dexmedetomidine Infusion During Sleeve Gastrectomy Recruiting
Virtual Lesion Segmentation and Mandibular Ameloblastoma Radiographic Safety Margin Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07320911 on ClinicalTrials.gov ↗ ← All trials in Egypt